Extract of Salacia oblonga lowers acute glycemia in patients with type 2 diabetes

American Journal of Clinical Nutrition

Volumn 86, Issue 1, 2007, Pages 124-130

  Williams, Jennifer A ^a   Choe, Yong S ^a   Noss, Michael J ^b   Baumgartner, Carl J ^b   Mustad, Vikkie A ^a  

^a ABBOTT LABORATORIES   (United States)

^b RADIANT RESEARCH   (United States)

Author keywords

Herbal extract; Postprandial glycemia; Salacia oblonga; glucosidase inhibitor

Indexed keywords

GLUCOSE; INSULIN; PLANT EXTRACT; SALACIA OBLONGA EXTRACT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AREA UNDER THE CURVE; ARM INJURY; ARTICLE; BACKACHE; BELCHING; CARBOHYDRATE DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FLATULENCE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; INFLUENZA; INJURY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULINEMIA; LEG INJURY; LIQUID; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; NON INSULIN DEPENDENT DIABETES MELLITUS; PLANT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SALACIA OBLONGA; SINUSITIS; VERTIGO;

SALACIA OBLONGA;

EID: 34447252787     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/86.1.124     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention: National Diabetes Fact Sheet, United States, 2005. Internet: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005. pdf (accessed 20 September 2006).
2. American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care 2002;26:917-32.
3. American Diabetes Association. National Diabetes Fact Sheet. Internet: http://www.diabetes.org/uedocuments/NationalDiabetesFactSheetRev.pdf (accessed 20 September 2006).
4. Wolf BW, Weisbrode SE. Safety evaluation of an extract from Salacia oblonga. Food Chem Toxicol 2003;41:867-74.
5. Yoshikawa M, Murakami T, Yashiro K, Matsuda H. Kotalanol. A potent α-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic Ayurvedic medicine Salacia reticulata. Chem Pharm Bull 1998;46:1339-40.
6. Matsuda H, Yoshikawa M, Morikawa T, Tanabe G, Muraoka O. Antidiabetogenic constituents from Salacia species. J Trad Med 2005;22:145-53.
7. Flammang AM, Erexson GL, Mecchi MS, Murli H. Genotoxicity testing of a Salacia oblonga extract. Food Chem Tox 2006;44:1868-74.
8. Flammang AM, Erexson GL, Mirwald JM, Henwood SM. Toxicological and cytogenetic assessment of a Salacia oblonga extract in a rat subchronic study. Food Chem Tox (in press).
9. Heacock PM, Hertzler SR, Williams JA, Wolf BW. A medical food containing an herbal α-glucosidase inhibitor on postprandial glycemia and insulinemia in healthy adults. J Am Diet Assoc 2005;105:65-71.
10. Collene AL, Hertzler SR, Williams JA, Wolf BW. Effects of a nutritional supplement containing Salacia oblonga extract and insulinogenic amino acids on postprandial glycemia, insulinemia, and breath hydrogen responses in healthy adults. Nutrition 2005;21:848-54.
11. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR. What does postprandial hyperglycemia mean? Diabet Med 2004;21:208-13.
12. Ahmed N, Babaei-Jadidi R, Howell S, Thornalley PJ, Beisswenger PJ. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005;28:2465-71.
13. Del Prato. In search of normoglycaemia in diabetes: controlling postprandial glucose. Int J Obes Relat Metab Disord 2002;26(supp):S9-S17.
14. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - the STOP-NIDDM trial. JAMA 2003;290:486-94.
15. Hanefield M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004;25:10-6.
16. Huang TH, Yang Q, Harada M, et al. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-α-mediated transcription of fatty acid metabolic genes. Toxicol Appl Pharmacol 2006;210:78-85.
17. Huang TH, Peng G, Li GQ, Yamahara J, Roufogalis BD, Li Y. Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-α. Toxicol Appl Pharmacol 2006;210:225-35.
18. Yoshikawa M, Shimoda H, Nishida N, Takada M, Matsuda H. Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats. J Nutr 2002;132:1819-24.
19. Mertes G. Safety and efficacy of acarbose in the treatment of type 2 diabetes: data from a 5-year surveillance study. Diabetes Res Clin Pract 2001;52:193-204.
20. 1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care 1998;21:1612-8.
21. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-77.
22. Barnard RJ, Jung T, Inkeles SB. Diet and exercise in the treatment of NIDDM. The need for early emphasis. Diabetes Care 1994;17:1469-72.
23. Yamaoka K, Tango T. Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2005;28:2780-6.
24. Schlundt DG, Rea MR, Kline SS, Pichert JW. Situational obstacles to dietary adherence for adults with diabetes. J Am Diet Assoc 1994;94:874-9.
25. Hall RF, Joseph DH, Schwartz-Barcott D. Overcoming obstacles to behavior change in diabetes self-management. Diabetes Educ 2003;29:303-11.